Clinical Trials Logo

Sphenopalatine Ganglion Block clinical trials

View clinical trials related to Sphenopalatine Ganglion Block.

Filter by:
  • None
  • Page 1

NCT ID: NCT04657952 Not yet recruiting - Clinical trials for Post-Dural Puncture Headache

Sphenopalatine Ganglion Block for Post-Dural Puncture Headache in Orthopedic Patients

Start date: December 10, 2020
Phase: Phase 4
Study type: Interventional

The aim of this study is to assess the efficacy, onset and duration of analgesia of sphenopalatine ganglion bock (SPGB) using lidocaine 4% with adrenaline as a treatment of postoperative Post dural puncture headache (PDPH) of orthopedic patients after lower limbs surgeries.

NCT ID: NCT04636034 Terminated - Covid19 Clinical Trials

The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection

Start date: January 12, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effect of the ganglion sphenopalatine block (SPG block) on persistent headache following acute COVID-19 infection.

NCT ID: NCT04479176 Completed - Clinical trials for Sphenopalatine Ganglion Block

Comparison of Two Methods of Transnasal Sphenopalatine Ganglion Block

Start date: March 10, 2021
Phase:
Study type: Observational

The transnasal sphenopalatine ganglion block(SPGB) is administered to patients with facial or head and neck pain. In the transnasal approach, the drip and topical methods are frequently used. We compared facial temperatures and VAS after transnasal SPGB.

NCT ID: NCT03966547 Withdrawn - Clinical trials for Postdural Puncture Headache

Changes in Cerebral Blood Flow (CBF) in Prone and Sitting Position Before and After GSP-block and Before and After Epidural Blood-patch: A Substudy of NCT03652714

Start date: May 2020
Phase: N/A
Study type: Interventional

The purpose of this optional sub-study to GSPB-2018 (NCT03652714) is to evaluate the changes in cerebral blood flow (CBF) under different conditions to understand if postdural puncture headache is caused by changes in the cerebral blood flow and if treatment normalises that change.

NCT ID: NCT03652714 Completed - Clinical trials for Postdural Puncture Headache

The Effect of Ganglion Sphenopalatine Block (GSP-block) Versus Placebo on Postdural Puncture Headache

Start date: September 19, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effect of the ganglion sphenopalatine block (GSP block) on postdural puncture headache.

NCT ID: NCT03430531 Terminated - Clinical trials for Post-Dural Puncture Headache

Effectiveness of Sphenopalatine Ganglion Block for Post-Dural Puncture Headache

Start date: May 31, 2019
Phase: Phase 2
Study type: Interventional

The objective of the study is to determine the effectiveness of Spheno-Palatine (SP) ganglion block to alleviate the pain of post-dural puncture headache (PDPH).

NCT ID: NCT02181205 Withdrawn - Clinical trials for Postdural Puncture Headache

Sphenopalatine Ganglion Block for Post-Dural Puncture Headache

Start date: November 2014
Phase: N/A
Study type: Interventional

The investigators are attempting to determine a less invasive method of treatment for postdural puncture headaches that can occur after regional anesthesia. The investigators will be evaluating the relief of headache with those subjects receiving treatment with a sphenopalatine ganglion block with bupivacaine versus placebo, evaluating the incidence of epidural blood patch, pain score of headache at 1 hour, then 24, 48, and 72 hours lower with post study treatment versus placebo, and potential side effects of those patients receiving study therapy as well as epidural blood patch.